Simplex Trading’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-62
| Closed | -$1K | – | 9811 |
|
|
2023
Q3 | $1K | Sell |
62
-69
| -53% | -$2.97K | ﹤0.01% | 8426 |
|
|
2023
Q2 | $10K | Buy |
131
+40
| +44% | +$3.24K | ﹤0.01% | 7442 |
|
|
2023
Q1 | $8K | Sell |
91
-288
| -76% | -$27.4K | ﹤0.01% | 7749 |
|
|
2022
Q4 | $36K | Sell |
379
-566
| -60% | -$82K | ﹤0.01% | 6262 |
|
|
2022
Q3 | $243K | Buy |
945
+809
| +595% | +$235K | ﹤0.01% | 4364 |
|
|
2022
Q2 | $25K | Buy |
136
+5
| +4% | +$478 | ﹤0.01% | 7356 |
|
|
2022
Q1 | $12K | Sell |
131
-4
| -3% | -$513 | ﹤0.01% | 8751 |
|
|
2021
Q4 | $53K | Sell |
135
-782
| -85% | -$172K | ﹤0.01% | 7199 |
|
|
2021
Q3 | $375K | Hold |
917
| – | – | ﹤0.01% | 4541 |
|
|
2021
Q2 | $363K | Buy |
917
+910
| +13,000% | +$425K | ﹤0.01% | 4661 |
|
|
2021
Q1 | $366K | Buy |
7
+4
| +133% | +$2.49K | ﹤0.01% | 3860 |
|
|
2020
Q4 | $100K | Sell |
3
-2
| -40% | -$795 | ﹤0.01% | 5441 |
|
|
2020
Q3 | $185K | Sell |
5
-3
| -38% | -$1.32K | ﹤0.01% | 4213 |
|
|
2020
Q2 | $410K | Buy |
8
+2
| +33% | +$892 | ﹤0.01% | 3157 |
|
|
2020
Q1 | $223K | Sell |
6
-6
| -50% | -$3.1K | ﹤0.01% | 3468 |
|
|
2019
Q4 | $838K | Buy |
12
+3
| +33% | +$2.06K | ﹤0.01% | 2247 |
|
|
2019
Q3 | $576K | Buy |
9
+2
| +29% | +$1.59K | ﹤0.01% | 2471 |
|
|
2019
Q2 | $629K | Buy |
7
+4
| +133% | +$2.75K | ﹤0.01% | 2360 |
|
|
2019
Q1 | $159K | Hold |
3
| – | – | ﹤0.01% | 3851 |
|
|
2018
Q4 | $78K | Sell |
3
-1
| -25% | -$395 | ﹤0.01% | 4096 |
|
|
2018
Q3 | $198K | Hold |
4
| – | – | ﹤0.01% | 3656 |
|
|
2018
Q2 | $179K | Hold |
4
| – | – | ﹤0.01% | 3620 |
|
|
2018
Q1 | $275K | Sell |
4
-3
| -43% | -$1.87K | 0.01% | 1037 |
|
|
2017
Q4 | $323K | Buy |
7
+5
| +250% | +$3.59K | 0.01% | 949 |
|
|
2017
Q3 | $44K | Hold |
2
| – | – | ﹤0.01% | 2422 |
|
|
2017
Q2 | $26K | Sell |
2
-3
| -60% | -$2.94K | ﹤0.01% | 3037 |
|
|
2017
Q1 | $57K | Buy |
5
+1
| +25% | +$931 | ﹤0.01% | 2243 |
|
|
2016
Q4 | $173K | Sell |
4
-1
| -20% | -$901 | 0.01% | 1148 |
|
|
2016
Q3 | $211K | Buy |
5
+2
| +67% | +$1.61K | 0.01% | 1000 |
|
|
2016
Q2 | $152K | Sell |
3
-1
| -25% | -$1.09K | 0.01% | 1181 |
|
|
2016
Q1 | $107K | Buy |
4
+2
| +100% | +$2.05K | 0.01% | 1298 |
|
|
2015
Q4 | $72K | Sell |
2
-2
| -50% | -$3.31K | 0.01% | 1623 |
|
|
2015
Q3 | $179K | Buy |
4
+1
| +33% | +$1.65K | 0.01% | 986 |
|
|
2015
Q2 | $12K | Buy |
3
+2
| +200% | +$3.1K | ﹤0.01% | 2926 |
|
|
2015
Q1 | $24K | Buy |
+1
| New | +$1.48K | ﹤0.01% | 2181 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4280 |
|
Other funds holding TCRT
MP
TRCT
SWM
Simplex Trading's TCRT Position: Q3 2024 in Review
Simplex Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 27 shares.
Simplex Trading first reported a position in TCRT in Q2 2015 and held it in 34 quarters. The position peaked at $449K in Q4 2015. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.
- Simplex Trading reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
- Simplex Trading sold 27 Alaunos Therapeutics shares in Q3 2024.
- Simplex Trading first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 34 quarters.
- Simplex Trading's Alaunos Therapeutics position peaked at $449K in Q4 2015.
- 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.
Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.